LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹0.65 Cr | ₹1.82 Cr | ₹2.44 Cr | ₹3.47 Cr | ₹3.66 Cr |
What is the latest Long Term Provisions ratio of LYKA LABS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹0.65 Cr |
| Mar2024 | ₹1.82 Cr |
| Mar2023 | ₹2.44 Cr |
| Mar2022 | ₹3.47 Cr |
| Mar2021 | ₹3.66 Cr |
How is Long Term Provisions of LYKA LABS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.65 Cr | -64.27 | |
| Mar2024 | ₹1.82 Cr | -25.27 | |
| Mar2023 | ₹2.44 Cr | -29.72 | |
| Mar2022 | ₹3.47 Cr | -5.27 | |
| Mar2021 | ₹3.66 Cr | - | |
Compare Long Term Provisions of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹166.1 Cr | -15.9% | -23.9% | -52.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -15.9% |
-23.9% |
-52.6% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses